FOR IMMEDIATE RELEASE
International Contract Research Organization to Implement Leading EDC Solution and
Meet Growing Demand for Medidata Rave
NEW YORK and LONDON – June 18, 2007 – Medidata Solutions, a global provider of electronic clinical data capture (EDC), management and reporting solutions, today announced that Chiltern Ltd, a full service contract research organization (CRO), has signed as a partner through Medidata’s ASPire to Win™ Program. With this partnership, Medidata will provide the tools and training that will enable Chiltern to implement Medidata Rave® to manage the company’s global Phase I–IV clinical development and late phase programs.
As an early adopter of EDC, Chiltern provides necessary technical project management, team training and site level training in support of EDC implementation and adoption. Chiltern’s dedicated EDC services to sponsors range from pilot programs to support of enterprise-level implementation. The company is looking to expand its service offerings, and after a review of the leading EDC vendors, Chiltern selected Medidata Rave.
“We selected Medidata Rave since it is a leading EDC solution for ease of use and implementation. Rave has received an outstanding response from our users,” said Glenn Kerkhof, Chiltern’s Chief Executive Officer. “We felt Medidata was an ideal partner because of our common commitment to quality and compliance to regulatory expectations, globally.”
Medidata’s ASPire to Win Program is a non-exclusive application service provider (ASP) partnership and business model. The program will allow Chiltern to meet sponsor demand for Medidata Rave and offer the platform in-house. As a result, Chiltern will be able to create new services revenue around the implementation of this industry-leading technology.
Chiltern will leverage Medidata’s ASPire to Win Program to build on the company’s established presence as an EDC provider. The Rave certification will allow Chiltern’s EDC Solutions Group to continue to expand their offerings for sponsors. This group currently provides advice and support for all EDC trials within Chiltern and assists with site and sponsor training as needed.
“Along with a progressive view of clinical technology, Chiltern has an impressive client base and a broad global reach,” said Tarek Sherif, CEO of Medidata Solutions. “Through our ASPire to Win Program, Chiltern will be able to quickly realize the benefits and ROI that Medidata Rave brings and build upon its existing position in the CRO market.”
About Chiltern
Established in 1982, Chiltern is a leading global contract research organization with extensive experience of running and staffing international Phase I to Phase IV clinical trials across a broad therapeutic range for a wide variety of clients. Chiltern employs more than 1000 people with 18 offices across the United States, Europe and India. Chiltern provides development services including Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions.
About Medidata Solutions Worldwide
Medidata Solutions helps the world’s leading pharmaceutical, biotechnology, medical device and research organizations maximize the value of their clinical research investments. Innovative process design, technology and services streamline clinical trials by providing early visibility to reliable clinical data—the lifeblood of every research organization. Working with companies and institutions both large and small, Medidata Solutions helps clinical researchers safely accelerate the process of bringing life-enhancing treatments to market—on six continents and in more than 80 countries. Medidata Solutions brings significant value to its broad client base with deep clinical experience and expertise in more than 20 therapeutic areas, projects in Phase I, II, III, IV, registries and surveillance, and studies with thousands of investigators and tens-of-thousands of subjects. For more information, please visit www.mdsol.com.
Contact:
Susan Lombardo
Lois Paul & Partners
781.782.5767
Susan_Lombardo@lpp.com
Catherine Lemercier
Chiltern Ltd.
760.707.5025
Catherine.Lemercier@chiltern.com